PO-1061: Evofosfamide sensitizes esophageal carcinomas to radiation without increasing normal tissue toxicity. (April 2018) - Spiegelberg, L.; Biemans, R.; Lieuwes, N.; Niemans, R.; Theys, J.; Yaromina, A.; Verhaegen, F.; Lambin, P.; Dubois, L.